Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 5, 2003

View Archived Issues

A role for IL-15 in the pathogenesis of psoriasis

New NHE inhibitors and their use reported by Aventis team

Protein prenyltransferase inhibitors newly identified at PPD Discovery

Ortho-McNeil scientists discover new androgen receptor modulators

Wyeth claims new agents able to inhibit PEPCK production and lower glucose and insulin levels

Novel sst receptor modulators prepared and tested at ChemBridge

GSK scientists present new beta2-adrenoceptor agonists for use in respiratory disorders

In vitro and in vivo antitumor effects of GW-572016

Bevacizumab plus docetaxel in metastatic breast cancer

Celecoxib supplementation allows more breast-conserving surgery for LABC

Antitumor effects of CCI-779 in breast cancer: final results of a phase II trial

Protein farnesyltransferase inhibitor R-115777 assessed in breast cancer model

Preliminary phase II results reported for vinflunine in metastatic breast cancer

Unique mechanism of action and binding sites for Avanir's anthrax antibodies

Barr begins Seasonale promotion

Barr to acquire Endeavor assets

Phase I study evaluates oral clofarabine in solid tumors

BioSante reviews third-quarter developments

Domantis creates potent dual-action domain antibodies

Orphan drug status for AEOL-10150 for ALS

Isotechnika's immunosuppressive pipeline expands with TKB-662

Kemin identifies molecules with activity against CMV

Lipid Sciences evaluates delipidation technology in nonhuman primate studies

MorphoSys antibodies bind to amyloid plaques in animal model of Alzheimer's disease

Sepracor discontinues development of Soltara

Zorbtive receives FDA approval for short bowel syndrome

Positive results for lead compounds in Theravance/GlaxoSmithKline alliance

Clinical studies of rhThrombin cleared to commence

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...